BRIEF-AstraZeneca and Shionogi extend Crestor licence

Fri Dec 27, 2013 2:21am EST

Related Topics

Dec 27 (Reuters) - AstraZeneca PLC : * And shionogi settle arbitration and extend licence agreement for crestor * Under the revised terms of the agreement, royalty payments from AstraZeneca to Shionogi has been modified to reduce the effective royalty rate in 2014-2015; the amount of this royalty rate reduction will be a low single-digit number * Agreement will extend the period of royalty payments from 2016 to 2023 * Source text for Eikon: * For more news, please click here

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.